कौन ज़िम्मेदार? KaunZimmedar

Adjudication Order in the matter of Exfinity Technology Fund

This order addresses alleged violations of SEBI's Alternative Investment Fund (AIF) Regulations by Exfinity Technology Fund and its associated parties, specifically concerning the failure to wind up the fund within the mandated timeline, exceeding the 25% limit for overseas investments, and failing to perform required semi-annual valuations.

Exfinity Technology Fund, Exfinity Venture Partners LLP, Mr. V Balakrishnan, Mr. Shailesh Ghorpada, Mr. Chinnu Senthilkumar, Mr. Nihar Ranjan, and Vistra ITCL (India) Limited.

  • SEBI alleged that the fund failed to wind up by August 14, 2022, as required by Regulation 29(7) of the AIF Regulations, despite seeking an unauthorized extension to August 2023.
  • SEBI alleged a breach of the 25% overseas investment limit (Regulation 15(1)(a)) between January 5, 2017, and July 26, 2023, when overseas investments reached 25.62% of investible funds.
  • SEBI alleged a violation of Regulation 23(2) for failing to undertake the mandatory valuation of investments for the half-year ended September 30, 2023.
  • SEBI alleged a violation of Regulation 28 for failing to intimate the Trustee (Vistra ITCL) about the overseas investment breach and valuation non-compliance.
  • The fund had investments worth Rs. 6.34 crore (at cost) yet to be liquidated as of December 30, 2024.
  • SEBI granted an additional liquidation period until April 24, 2025, via circulars dated April 26, 2024, and July 09, 2024.

Written from the document by AI, and checked against it. The original below is authoritative.

The original document

Order 2026-06-25
Tap “Open the PDF” above to view this document.
Document details
Official titleAdjudication Order in the matter of Exfinity Technology Fund
Source bodySecurities & Exchange Board of India (SEBI) — enforcement orders
Reference numberOrder/JS/DP/2026-27/32450-32456
Statusclosed (order)
Year2026
Closing date
Documents1

Discussion (0)

Citizens discussing these documents. A discussion space — nothing here is verified fact or an official finding. Reading is free; sign in to take part.

Open discussion (0) →